Treatment Goals in Psoriasis: Which Outcomes Matter Most?

Autor: Rima I. Ghamrawi, Steven R. Feldman, Steven A. Svoboda, Dorellie A Owusu
Rok vydání: 2020
Předmět:
Zdroj: Svoboda, S A, Ghamrawi, R I, Owusu, D A & Feldman, S R 2020, ' Treatment Goals in Psoriasis : Which Outcomes Matter Most? ', American Journal of Clinical Dermatology, vol. 21, no. 4, pp. 505-511 . https://doi.org/10.1007/s40257-020-00521-3
ISSN: 1179-1888
1175-0561
DOI: 10.1007/s40257-020-00521-3
Popis: Psoriasis is a chronic immune-mediated inflammatory disease that predominantly affects the skin and joints. Its detrimental effects on the physical, psychosocial, and emotional well-being of patients leads to a significant reduction in quality of life (QoL). The goals of treatment focus on decreasing disease severity and improving QoL for patients; accomplishing these goals requires physicians to understand both the full impact of the disease on a patient’s life and the outcomes that matter most to patients. The use of outcome measures, both physician- and patient-reported, can assist clinicians in evaluating the disease burden and its effect on QoL and in identifying patient preferences for treatment, ultimately enhancing quality of care. However, current outcome measures have many limitations and do not adequately capture patients’ needs and priorities. Nevertheless, physicians treating patients with psoriasis are encouraged to utilize these instruments while remaining cognizant of each of their limitations. As there is no consensus on an outcome measure that fully encompasses the complexities of psoriasis and its impact on patients, instruments that are appropriate and applicable to dermatologists and their patients should be developed.
Databáze: OpenAIRE
Externí odkaz: